← Open Payments lookup

JAMIE SMITH: Open Payments

NPI 1124363874 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$749 in 37 payments from 11 companies in 2025. Trend: 2023 $580 · 2024 $668 · 2025 $749

Food & beverage: $749
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$196
Teva Pharmaceuticals USA, Inc.5$103
Avadel CNS Pharmaceuticals, LLC5$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$87
E.R. Squibb & Sons, L.L.C.4$83
Alkermes, Inc.2$49
Janssen Pharmaceuticals, Inc2$34
HARMONY BIOSCIENCES LLC1$34
IDORSIA PHARMACEUTICALS US INC1$26
Axsome Therapeutics, Inc.1$23

Products named: REXULTI, LUMRYZ, CAPLYTA, COBENFY, UZEDY, ARISTADA, INVEGA SUSTENNA, WAKIX.

Industry payments across GA — which companies pay providers there.